3-异丁氧基-2-环己烯酮 | 23074-59-1

• 物质功能分类: 有机原料 - 酮类化合物
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 3-异丁氧基-2-环己烯酮
• 英文名称: 3-isobutoxycyclohex-2-en-1-one
• 英文别名: 3-isobutoxy-2-cyclohexenone；3-isobutoxy-2-cyclohexen-1-one；3-isobutoxycyclohex-2-enone；3-Isobutoxy-2-cyclohexenon；3-(2-methylpropoxy)cyclohex-2-en-1-one
• CAS: 23074-59-1
• 化学式: C₁₀H₁₆O₂
• mdl: MFCD00143170
• 分子量: 168.236
• InChiKey: FKJAZODXPHIGOL-UHFFFAOYSA-N

物化性质

• 沸点：
  257.18°C (rough estimate)
• 密度：
  0.9812 (rough estimate)
• 稳定性/保质期：
  在常温常压下稳定，应避免接触强氧化剂。

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2914509090
• 安全说明：
  S24/25
• 储存条件：
  将物品存放在密封的容器中，并储存在阴凉、干燥的地方。

SDS

Name:	3-Isobutoxy-2-cyclohexen-1-one 99% Material Safety Data Sheet
Synonym:	3-(2-Methylpropoxy)-2-cyclohexen-1-one; 3-Isobutoxycyclohex-2-en-1-on
CAS:	23074-59-1

Section 1 - Chemical Product MSDS Name:3-Isobutoxy-2-cyclohexen-1-one 99% Material Safety Data Sheet
Synonym:3-(2-Methylpropoxy)-2-cyclohexen-1-one; 3-Isobutoxycyclohex-2-en-1-on

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
23074-59-1	3-Isobutoxy-2-cyclohexen-1-one	99	245-414-4

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 23074-59-1: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Clear liquid
Color: clear, colorless
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Not available.
Specific Gravity/Density: Not available.
Molecular Formula: C10H16O2
Molecular Weight: 168.24

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 23074-59-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3-Isobutoxy-2-cyclohexen-1-one - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 23074-59-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 23074-59-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 23074-59-1 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

合成制备方法

---

用途

---

反应信息

• 作为反应物：
  描述：

  3-异丁氧基-2-环己烯酮 在 lithium aluminium tetrahydride 、 盐酸 作用下， 以 乙醚 、 水 为溶剂， 反应 0.5h， 以40%的产率得到2-环己烯-1-酮
  参考文献：
  名称：

  钯催化的不对称烷基化合成具有全碳四元立构中心的环戊烷和环庚烷核心结构

  摘要：

  已经开发了嵌入多种天然产物中的环戊烷和环庚烷核心结构的通用催化不对称路线。我们不同策略中的中心立体选择性转化是七元β-酮酯的对映选择性脱羧烷基化形成α-季插烯酯。认识到添加氢化物或有机金属试剂所产生的 β-羟基酮的异常反应性，使得能够通过环收缩途径获得 γ-季酰基环戊烯或通过羰基转座途径获得 γ-季环庚烯酮。通过制备单环、双环和三环衍生物探索了这些化合物的合成应用，这些衍生物可以作为复杂天然产物全合成的有价值的中间体。这项工作补充了我们之前在环己烷系统方面的工作。

  DOI：

  10.1016/j.tet.2011.10.031
• 作为产物：
  描述：

  异丁醇 、 1,3-环己二酮 在 对甲苯磺酸 作用下， 以 苯 为溶剂， 以95%的产率得到3-异丁氧基-2-环己烯酮
  参考文献：
  名称：

  （ - ）- ar -Tenuifolene的催化对映选择性全合成

  摘要：

  从商业上可买到的3-甲基环己-2-烯酮16（3个步骤，总产率75％）进行芳香族倍半萜（-）- ar- teunifolene（1）的首次催化不对称全合成。富含对映体的3,3-二取代的环己酮11是由Pd（II）催化的对映选择性（对甲苯基）硼酸在90％ee中加到3-甲基环己-2-烯酮16中获得的，这是关键的中间体。对该对映体富集的产物进行非对映选择性甲基锂加成后再进行脱水即可直接获得（-）- ar- teunifolene（1）。

  DOI：

  10.1016/j.tetlet.2020.151850

文献信息

• An efficient synthesis of (±)-crinane using an intramolecular azide-olefin cycloaddition
  作者：Jeffrey M Schkeryantz、William H Pearson

  DOI：10.1016/0040-4020(95)01098-x

  日期：1996.2

  proceeds by intramolecular 1,3-dipolar cycloaddition of the azide onto the alkene followed by loss of nitrogen from the triazoline intermediate to give an imine. Reduction of the imine 12 with sodium cyanoborohydride in acetic acid/THF gave (3aR∗, 7aR∗)-3a-[3,4-methylenedioxy)phenyl]-2,3,3a,4,5,6,7,7a-octahydroindole (13). Warming 13 with Eschenmoser's salt provided (±)-crinane (1). The synthesis of (±)-crinane

  将3-（2-叠氮基乙基）-3- [3,4-（亚甲基二氧基）苯基]环己-1-烯（2）在甲苯中回流24小时，得到3a- [3,4-亚甲基二氧基）苯基] -3,3a ，4,5,6,7-六氢-2 H-吲哚（12）的定量收率。该反应通过将叠氮化物的分子内1，3-偶极环加成到烯烃上，然后从三唑啉中间体中损失氮而得到亚胺来进行。用氰基硼氢化钠在乙酸/ THF中还原亚胺12，得到（3aR ∗，7aR ∗）-3a- [3,4-亚甲二氧基）苯基] -2,3,3a，4,5,6,7,7a-八氢吲哚（13）。升温13与Eschenmoser的盐的形式提供（±）-crinane（1）。由环己烯酮合成（±）-氢化正庚烷（1）分8步完成，总产率为23％。
• A Unique Skeletal Rearrangement of a Bicyclo[3.3.1]nonanetrione to a Tetrahydroquinolin-2(1H)-one System
  作者：Jing Wu、Yong Liang、Jian-Xin Li、Qi Shen、Fang Liu、Yu-Chao Zhang、Jie Wang、Lei Zhang、Yue Wang、Hong-Xi Xu、Zhuzhou Shao、Yang Cao

  DOI：10.1055/s-0037-1610187

  日期：2018.8

  The unexpected formation of a 4-hydroxytetrahydroquinolin-2(1H)-one from a bicyclo[3.3.1]nonanetrione system and an amino alcohol in the presence of TsOH is reported. The mechanism of this transformation was studied by DFT calculations. The reaction provides an entry to the synthesis of highly functionalized 4-hydroxytetrahydroquinolin-2(1H)-ones.

  据报道，在 TsOH 存在下，由双环 [3.3.1] 壬三酮系统和氨基醇意外形成 4-羟基四氢喹啉-2(1H)-one。通过DFT计算研究了这种转变的机制。该反应为高度官能化的 4-羟基四氢喹啉-2(1H)-酮的合成提供了一个入口。
• Enantioselective Total Synthesis of Nigelladine A via Late-Stage C–H Oxidation Enabled by an Engineered P450 Enzyme
  作者：Steven A. Loskot、David K. Romney、Frances H. Arnold、Brian M. Stoltz

  DOI：10.1021/jacs.7b05196

  日期：2017.8.2

  alkaloid nigelladine A is described. Strategically, the synthesis relies on a late-stage C–H oxidation of an advanced intermediate. While traditional chemical methods failed to deliver the desired outcome, an engineered cytochrome P450 enzyme was employed to effect a chemo- and regioselective allylic C–H oxidation in the presence of four oxidizable positions. The enzyme variant was readily identified from

  描述了对二萜类生物碱尼古拉定A的对映选择性全合成。从战略上讲，该合成依赖于高级中间体的后期C–H氧化。尽管传统的化学方法无法提供理想的结果，但工程化的细胞色素P450酶在存在四个可氧化位置的情况下，实现了化学和区域选择性烯丙基CH的氧化。可从三种酶的集中文库中轻松鉴定出酶变体，从而无需大量筛选即可完成合成。
• Assessing the Substrate Selectivities and Enantioselectivities of Eight Novel Baeyer−Villiger Monooxygenases toward Alkyl-Substituted Cyclohexanones
  作者：Brian G. Kyte、Pierre Rouvière、Qiong Cheng、Jon D. Stewart

  DOI：10.1021/jo030253l

  日期：2004.1.1

  4-alkyl-substituted cyclohexanones tested, enzymes were discovered that afforded each of the corresponding (S)-lactones in ≥98% ee. This was also true for the 2-alkyl-substituted cyclohexanones examined. The situation was more complex for 3-akyl-substituted cyclohexanones. In a few cases, single Baeyer−Villiger monooxygenases possessed both high regio- and enantioselectivities toward these compounds

  最近，从居住在污水处理厂的细菌中克隆了编码八种拜尔-维利格单加氧酶的基因。我们进行了系统的研究，其中每个新克隆的酶以及不动杆菌属的环己酮单加氧酶。NCIB 9871用于氧化15种不同的烷基取代的环己酮。底物组包括相等数量的2-，3-和4-烷基取代的化合物，以探测每种酶对一系列同源的重要合成化合物的立体选择性。对于所有测试的4-烷基取代的环己酮，发现了能够提供相应的相应酶（See≥98％ee的内酯。对于所检查的2-烷基取代的环己酮也是如此。对于3-烷基取代的环己酮而言，情况更为复杂。在少数情况下，单一的Baeyer-Villiger单加氧酶对这些化合物具有很高的区域选择性和对映选择性。但是，更常见的是，它们仅显示出一种类型的选择性。尽管如此，具有这种性质的酶仍可以用作两步生物过程的一部分，在该过程中，最初的动力学拆分随后是对分离的光学纯酮的区域选择性氧化。
• Synthesis and evaluation of tetrahydroquinolin-2(1H)-one derivatives as novel anti-pancreatic cancer agents via targeting autophagy
  作者：Qi Shen、Jie Wang、Chen-Xi Liu、Wei Cui、Lei Zhang、Yu-chao Zhang、Yue Wang、Jing Wu、Jian-Xin Li

  DOI：10.1016/j.ejmech.2019.03.013

  日期：2019.5

  strategies are urgently needed. During a project aiming at discovery of anticancer agents, we performed a structure modification on polycyclic polyprenylated acylphloroglucinols (PPAPs) skeleton, and discovered that PPAP rearranged to a tetrahydroquinolin-2(1H)-one feature. Here, series of tetrahydroquinolin-2(1H)-one derivatives were designed, synthesized and evaluated against a highly metastatic human

  胰腺癌是最致命的肿瘤之一，由于其对营养饥饿的显着耐受性，其5年生存率不到6％，因此迫切需要新的药物和治疗策略。在一个旨在发现抗癌药的项目中，我们对多环多亚丙基化酰基间苯三酚（PPAP）骨架进行了结构修饰，并发现PPAP重排为四氢喹啉2（1 H）-一个特征。在此，设计，合成和评估了一系列四氢喹啉-2（1 H）-one衍生物对高转移性人胰腺癌细胞系（PANC-1）的构效关系。其中，衍生物11k对IC表现出最强的抑制活性营养剥夺条件下4.9μM的50值。相比之下，所有这些衍生物在正常营养条件下对PANC-1细胞均显示出低细胞毒性，这表明这些衍生物似乎具有替代的肿瘤细胞死亡机制，并导致毒性更低。进一步的评估表明，在营养缺乏的条件下，11k减少了菌落的形成并诱导了PANC-1的凋亡，并呈浓度依赖性。在体内研究中，11k显着抑制了裸鼠的肿瘤发展和体重。初步机理研究表明，11k明显下调了LC3-II的表